A medical device in development.

Hemokinetix is an early-stage medical device company. The device is in pre-market development. Technical materials are available to qualified parties under executed mutual non-disclosure agreement.

Stage Pre-market

Regulatory Pre-submission

01 — Status

Current development state.

Hemokinetix is in pre-market development. The information below reflects current state and is subject to change.

Stage ActivePre-market development

Regulatory Pre-submission planning

02 — Founder

Founded and led by Noah McKenna.

Noah McKenna is the founder and CEO of Hemokinetix. Background and relevant experience are shared with qualified investors and advisors under non-disclosure agreement.

Noah McKenna

Founder & CEO

03 — Contact

Selective inbound. Considered response.

Hemokinetix is currently engaging selectively with medical device investors and regulatory advisors. We respond to qualified inquiries within five business days.

Investor inquiries

investors@hemokinetix.com

For seed and Series A medical device investors. Brief overview returned by reply; technical materials under mutual NDA.

Advisor inquiries

advisors@hemokinetix.com

For FDA-experienced regulatory, clinical, and quality advisors. Please include relevant clearance experience.